Legal Representation
Attorney
Larry L. Coats
USPTO Deadlines
Next Deadline
28 days remaining
NOA E-Mailed - SOU Required
Due Date
August 25, 2025
Extension Available
Until February 25, 2026
Application History
22 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 22, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 16, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 16, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Jul 16, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Jun 24, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jun 24, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Mar 24, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
Mar 24, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Feb 25, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Dec 31, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Dec 31, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Dec 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Dec 6, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Dec 5, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 5, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 24, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Oct 24, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 24, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Oct 17, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 11, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 4, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Non-commercial pharmaceutical dispensing services, namely, dispensing free prescription drugs being pharmaceuticals donated by pharmaceutical manufacturers and provided in the course of administering patient assistance programs on behalf of pharmaceutical manufacturers
First Use Anywhere:
20240300
First Use in Commerce:
20240300
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
PHARMACY